Two monoclonal antibodies (mabs) which recognized the 68 kDa subunit of the rat neurofilament triplet were isolated. In immunoblots with SDS-solubilized and reduced proteins, these mabs recognized their epitopes equally well in embryonic and in adult tissue. However, these epitopes were developmentally regulated in paraformaldehyde-fixed rat brain sections. They were abundant in all compartments of differentiating neurons, whereas in mature neurons their presence was markedly attenuated, with a moderate abundance in perikarya and larger dendrites and low concentrations in axons. Thus, a differential developmental modification, possibly involving the masking of an epitope, is demonstrated for the small neurofilament polypeptide in rat and monkey brain tissue.
INTRODUCTION
How can molecules be developmentally regulated in the nervous system? Some neuronal molecules are expressed transiently at a certain developmental stage 11"23"33'38. For the sake of simplicity, it can be assumed though, that most regulative mechanisms operate on the post-translational level, through modifications inducing conformational changes, masking sites, etc., in pre-existing neuronal proteins. This is particularly obvious for the structural proteins of the cytoskeleton: functional heterogeneity in its components enables the neuronal cytoskeleton to regulate the plasticity of neuronal connections. Not only can slightly heterogeneous isoforms create different functional states of the neuronal cytoskeleton during development, but they can also be distributed in a differential manner between spatial compartments, such as axons, dendrites, and cell bodies. Indeed, a variety of temporal and spatial modifications have been reported for the components of neuronal microtubules 2"1531 and neurofilaments20, 21,36,51. In the two higher molecular weight proteins of the neurofilament triplet, NF-H and NF-M, functional heterogeneity is introduced by differential phosphorylation in different cellular compartments after the filament has been assembled from the subunits 24"35"45. Studies with monocional antibodies (mabs) that recognize phosphorylation-dependent epitopes showed that the neurofilament proteins in axons bear a larger number of COOH-terminal phosphate groups than those in cell bodies 26"27" 36. 48, 49 . Moreover, the phosphorylation of the highest molecular weight neurofilament protein, NF-H, is developmentally controlled and takes place late in neuronal development, with the final establishment of the axonal growth pattern s14'26. In peripheral nerve regeneration NF-H phosphorylation was shown to coincide with the return of normal nerve structureS; in chicken development it is concomitant with the functional maturation of the axons ~3.
Some heterogeneity in neurofilament proteins cannot be attributed to different phosphorylation states; e.g. a mab which was proven to be phosphorylation-independent recognized a developmen-tally late isoform of NF-H in tissue sections and immunoblots 52.
Previously, no microheterogeneity was reported for the distribution of the small neurofilament protein, NF-L. Although this protein is phosphorylated as well, there is no differential spatial distribution between the phosphorylated and the nonphosphorylated form 36.
Here we now report a developmentally regulated epitope on the small neurofilament protein of mammalian CNS neurons which we identified with the mabs A1 and B3. In immunoblots our mabs recognized the 68 kDa peptide of the neurofilament triplet. However, comparing the developmental time course of NF-L expression with our mabs and a commercially available mab to the same protein, NR4 (ref. 16 ), revealed differential regulation of epitopes.
We can show by immunohistochemical stains that NR4 reacts with an epitope that appears during the later stages of neuronal differentiation and gradually increases towards adult levels. Our antibodies, on the other hand, detect an epitope that reaches a maximal concentration in neurons while they differentiate, then decreases when the neurons have matured. Using immunoblotting technique, however, we were unable to show differences in the developmental time course of NF-L expression with our mabs and NR4.
Thus, we report two neurofilament epitopes which are regulated differently during development. Both of these epitopes are situated on the 68 kDa neurofilament peptide and can be detected on this protein in Western blots. In intact neurofilaments, however, one of these epitopes is primarily available to antibody binding early during neuronal differentiation, while the other becomes accessible only at a later stage.
MATERIALS AND METHODS

Antibodies
Monoclonai antibodies against vimentin and glial fibrillary acidic protein (GFAP), as well as fluorescent and horseradish peroxidase-(HRP) conjugated second antibodies, were bought from Dakopatts, Hamburg, F.R.G. NR4 hybridoma supernatant was the kind gift of Dr. M. Osborn 16, and affinity purified rabbit antiserum against NF-M was the kind gift of Dr. G. Shaw 3'.
Production of antibodies
Immunizations were carried out either by injecting mice with forebrain homogenates of day 20 chicken embryos or in vitro using the method of Luben and Mohler 3° by incubating spleen cells for 4 days on top of a culture of rat hippocampal neurons. Immunization media contained an equal volume of thymocyte-conditioned medium and 20/~g/ml adjuvant peptide (Sigma). Fusions were carried out with the myeloma lines FO or Sp2/0 using 35% polyethylene glycol/15% DMSO. Fused hybrids were selected by addition of 50/~M hypoxanthine and 10/tM azaserine to the growth medium. All hybridomas were recloned at least 3 times by limited dilution. Antibodies from culture supernatant were stored in Fig. 1 . A rat hippocampal neuron grown for 4 days in culture and stained with the mab A1 after fixation with paraformaldehyde. A fibrillary, cytoskeletal staning pattern is visible in cell body, dendrites, and axon. An evenly distributed, punctate background stain on the coverslip occurred with all neurofilament antibodies. Bar = 10 urn. 
Primary cell cultures
Rat hippocampal cell cultures were prepared as described elsewhere 3. Briefly, hippocampi were taken out at embryonic day 18, trypsinized and mechanically dissociated. Cells were plated onto polylysin-coated glass coverslips and grown serumfree either on a feeder layer of primary cortical astrocytes 34 or directly with N2 hormone cocktail 6, with glucose content adjusted to 6 g/1.
Tissue preparations
For crude homogenates, tissues were doused in PBS and sonified. Intermediate filaments from forebrain were isolated by differential salt extraction 17. Microtubule proteins from forebrain were prepared by in vitro assembly (one cycle) 53. Protein content of preparations was measured according to Peterson 37. 
Immunohistochemistry
For immunofluorescent stains, cultured cells or slide-mounted cryostat sections of unfixed rat brain were fixed in a paraformaldehyde solution (either 4% for 30 min, or 2% for 50 rain), and incubated with specific antibodies, followed by FITC-conjugated rabbit anti-mouse Ig antiserum diluted 1:50 (1 h; 37 °C).
For peroxidase-anti-peroxidase (PAP) stain, rat brains were perfused with 2% paraformaldehyde/ 0.1% glutaraldehyde for 50 rain, followed by 10% sucrose in Tris-buffered saline, left to settle in 30% sucrose, sectioned on a freezing microtome (40-60 /~m), and incubated floating in specific antibodies (4 h; 37 °C), followed by rabbit anti-mouse Ig antiserum (1:25; 1 h; 37 °C) and mouse PAP complex (1:150; 1 h at room temperature). Color was devel-oped with diaminobenzidine. All sections were pretreated with H2OJmethanol to destroy endogenous peroxidases. For each antibody, parallel samples preincubated with different concentrations of Triton X-100 (0-0.5%; 15 min) were stained to control for effects due to incomplete permeabilization.
SDS-PA GE and Immunoblots
SDS-PAGE was carried out using the method of Laemmli 25 , and transferred to nitrocellulose using the method of Towbin 47. Nitrocellulose was reacted with specific antibody (-2 h; 37 °C), then with peroxidase-conjugated rabbit anti-mouse Ig antise- A negative control was prepared for all immunological stains by incubating parallel samples with myeloma supernatant rather than specific antibody.
RESULTS
In several fusions, mabs were generated against embryonic chick forebrain and neonatal rat hippocampus. Twenty-six of the isolated hybridoma clones recognized neurons in paraformaldehyde-fixed frozen sections of the rat brain, To screen for developmentally regulated antigens, we compared antibody staining in sections from 7-day-old and adult rat brain: 40% of the antibodies stained the cell bodies of 7-day-old neocortical and hippocampal neurons significantly more intensely than in the adult rat brain, therefore recognizing antigens that are present in higher concentrations in differentiating neurons than in adult neurons. Six antibodies exhibited fibrillary staining patterns in cultured CNS neurons, suggesting an epitope located on one of the neuronal cytoskeletal filament systems (Fig. 1) .
Two of these six antibodies, A1 (generated against chick) and B3 (generated against rat), were further characterized and were found to react similarly. Therefore, we will show figures only for monoclonal antibody B3.
Differences in staining intensities between cell bodies of differentiating and adult neurons were more pronounced when the tissue was fixed with paraformaidehyde, than when the tissue was fixed with methanol or acetone (10 min; -20 °C). Therefore, paraformaldehyde was used routinely as fixative for all histological stains.
In immunoblots prepared from adult or 7-day-old forebrain or hippocampus homogenates, the 6 antibodies recognized a protein with a molecular weight of ca. 70 kDa. The antibodies were specific for CNS tissue, since they did not react with homogenized adult rat liver or kidney (Fig. 2) . In order to determine whether the 70 kDa band represents a microtubule or intermediate filament protein, these two cytoskeletal filament systems were purified from rat forebrain, using standard procedures (see Materials and Methods section). Both mabs recognized a band at 68 kDa on immunoblots prepared from Fig. 4 . B3 and NR4 neurofilament epitopes in the cerebral cortex of a 7-day-old rat. Both epitopes are present in fibers in the cortical white matter to a similar extent (arrows), but only the B3 epitope can be detected in cell bodies and outgrowing apical dendrites of differentiating neurons in the cortical plate. Non-specific staining of meninges occurred in all tissue sections, including negative controls. Bar = 0.1 mm. intermediate filaments. They did not react with immunoblots prepared from microtubule proteins (Fig. 2) . Thus our antibodies appear to recognize the 68 kDa-peptide of the neurofilament triplet, NF-L.
Further evidence that these mabs bind to the 68 kDa neurofilament protein was obtained by reacting our antibodies along with several commercially available intermediate-filament antibodies, on adjacent immunoblot strips prepared from purified intermediate filament proteins (Fig. 3) . As is shown by the Coomassie stain, this preparation contains only a few distinct protein bands. Our antibodies recognized the same band as the monoclonal antibody against NF-L, NR4 (ref. 16 ), whereas antibodies against vimentin, GFAP, and the 150 kDa neurofilament component (NF-M) recognized other protein bands. These results strongly suggest that our mabs bind to an epitope on the 68 kDa neurofilament protein.
We decided to investigate the developmental time course during which epitopes on the 68 kDa neurofilament protein are expressed. We did so by perfusing rats of different ages with paraformaldehyde, preparing frozen microtome sections of the brain, and reacting them with our antibodies, as well as the NR4 antibody. Fig. 4 shows a comparison between the neurofilament epitopes in the cortex of a 7-day-old rat. At this age cell bodies and dendritic processes of differentiating pyramidal cells in the developing cortical layers were strongly stained by B3. NR4, on the other hand, showed no detectable immunoreac- tivity with cell bodies or dendrites of differentiating cortical cells, although axonal fibers in the cortical white matter were equally well labelled by both antibodies. During subsequent cortical development, the presence of the NR4 epitope in neuronal cell bodies gradually increased, while the abundance of the B3 and A1 epitopes generally declined.
in the 10-day-old rat cerebellum, dendrites of the Purkinje cells are differentiating, and only axons of climbing fibers in the white matter are present (Fig.  5) . At this stage, B3-1abelled cell bodies and dendritic trees of Purkinje cells, as well as climbing fiber axons are seen. NR4 stained the Purkinje cell bodies weakly, but it labelled the axons in the cerebellar white matter as strongly as those in the cortical white matter.
In adult rats on the other hand, the presence of the B3 epitope was markedly reduced, and largely restricted to cell bodies and larger dendrites ( Fig. 6 ; cortex). The degree of immunoreactivity in fiber systems was somewhat variable in different regions with our mabs; but on the whole, large fiber systems, such as corpus callosum, fornix, and striatal tracts, were stained moderately by B3 and poorly by A1. NR4, in contrast, strongly detected the fine dendritic processes of cortical neurons. Fiber tracts also displayed a very prominent stain with NR4.
In the adult cerebellum, the B3 epitope could be demonstrated in cell bodies and larger dendrites of the Purkinje cells (Fig. 7) . B3 and A1 staining of axonal arborizations in the adult cerebellum was moderate, as in the basket cell terminals around the Purkinje cell bodies, or weak, as in the cerebellar white matter. In contrast, these axonal structures were the prominent features of the NR4 staining pattern. NR4 did not label the cell bodies and dendrites of the Purkinje cells.
The differences in staining pattern that we detected did not seem to be restricted to one species: in brain sections of adult cats and macaque monkeys, Fig. 6 . B3 and NR4 neurofilament epitopes in the cerebral cortex of an adult rat. The NR4 epitope is detectable along multiple small dendritic arborizations of cortical neurons, whereas the B3 epitope is scarce and does not extend beyond the primary dendrites. Bar = 0. I mm. differences in immunoreactivity of cell bodies and axonal structures identical to those in rat brain were observed. However, we did not have the opportunity to investigate developing brain of these species. Fig.   8 shows sections through motor cortex of Macaca fascicularis where differences in the subcellular distribution of epitopes are even more clearly demonstrated than in rat brain. Restriction of the B3 stain to proximal dendrites and cell bodies is visible in the extraordinarily large pyramidal neurons of layer V. NR4, on the other hand, recognized a multitude of fine neurofibrils in dendrites and axons, whereas in the cell bodies the NR4 stain seemed to be concentrated in a submembraneous rim.
When cell cultures from rat cerebral cortex or hippocampus as in vitro systems of differentiation were examined, staining of neurons 3-4 days in culture was frequently observed with our antibodies (See Fig. 1 ). Under the same conditions, a delayed appearance of NR4 epitopes (only after 7 days or more in vitro) was noted; the observed abundance was low and was predominantly located in the axons of only a few cells (data not shown; comparable findings in ref. 42) .
In all immunohistochemical experiments, parallel stains for the other two intermediate filaments present in brain, vimentin and GFAP, were performed. The tissue distribution of these antigens showed no overlap with our neurofilament epitopes at any of the ages we investigated. Thus, we can exclude any cross-reactivities of our antibodies with other intermediate filaments in tissue stains. Fig. 9 is a schematic representation of a comparison between the subcellular distribution of the epitopes recognized by our mabs and by NR4 in a differentiating cortical pyramidal cell and in a mature cortical neuron. After establishing a significant difference in the distribution of the neurofilament epitopes recognized by our antibodies and NR4, we then wanted to show these different epitope specificities in immunoblots as well. However, we were unable to detect any significant differences in the developmental time course of immunoreactivity. This is demonstrated in Fig. 10 for forebrain homogenates from rats aged embryonic day i8 to postnatal day 21. On Western blots, both with our antibody and with NR4, the first NF-L proteins were detected at around postnatal day 3-5: their abundance then increases gradually, until it reaches a steady state when neuronal differentiation is completed at the end of the second postnatal week. Western blot analysis did not show a reduction in neurofilament proteins recognized by our antibodies after the first postnatal week, in contrast to the reduction in neurofilament staining in adult rat and monkey brain.
The possibility that this unexpected result was due to our antibodies recognizing a different protein after aldehyde fixation was excluded by fixing immunoblots with paraformaldehyde before reacting them with the antibodies: both A1 and B3 still recognized the 68 kDa protein, and only this band, after aldehyde fixation. Thus, we conclude that the mabs recognize an epitope on the 68 kDa neurofilament protein in immunoblots and in some neurofibrils in tissue sections, but in other neurofibrils the epitope obviously becomes unavailable for antibody binding. 
DISCUSSION
In this paper we report differential regulation of antigenic sites on the small neurofilament protein, NF-L, in development and in subcellular compartments. The biochemical nature of the developmentally regulated modification is as yet unknown to us, but a clue comes from the fact that it can be observed only in tissue sections after paraformaldehyde fixation.
The developmental time coursewe see with our antibodies in immunoblots coincides with the time course of neurofilament expression as has been described in the literature: in chick, NF-L is first detected anytime between the last mitosis of the neuronal precursors and the end of their migration, depending upon neuronal type 4. In rats, NF-L is expressed de novo in terminally differentiated nerve cells, coincident with the initial axonal extension; it gradually replaces the vimentin present in mitotic neuroepithelial cells 9'29"46. For example, it is present in the ganglion cells of rat retina from embryonic day 15.5 on, in retinal horizontal cells after birth concomitant with the formation of layers 41, and in rat optic nerve from embryonic day 15 on 14.
Thus, the overall concentration of neurofilaments in the brain increases gradually following neuron production 8, until a terminal level is attained upon maturation of neuronal pathways. 
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Adult / A1/B3 NR4 Fig. 9 . Subcellular distribution of A1/B3 and NR4 neurofilament epitopes during differentiation and in the mature state is summarized in a schematized drawing of a cortical pyramidal neuron. During neuronal differentiation A1 and B3 epitopes are abundant in all parts of the cell, while the NR4 epitope is restricted to its axon. In adult neurons, the abundance of A1 and B3 epitopes generally decreases; it decreases more in axons and distal dendrites than in the cell body and the primary dendrites. The NR4 epitope is abundant in all parts of adult neurons, except in the inner regions of the cell body.
The time course of NF-L expression in forebrain homogenates, as detected with B3 and NR4, coincides well with the time of cortical layer formation. On the other hand, the developmental and subcellular distribution pattern observed in the tissue in situ with either our antibodies or the NR4 antibody can account for only a fraction of the existing 68 kDa neurofilament proteins, as the mabs obviously stain partially overlapping sets of neurofibrils. Thus, we conclude that the antibodies recognize epitopes that are inaccessible in some filaments in situ, and remain inaccessible during our relatively mild perfusion conditions, which leave 3-dimensional structures intact. Upon stronger denaturation of the protein,
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97- e.g. after treatment with SDS and reducing agents, the epitopes become exposed to antibody binding.
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In addition to our immunoblot data, the following indirect evidence makes it unlikely that our antibodies detect a specific phosphorylation state of NF-L, similar to the phosphorylation-dependent epitopes on NF-H and NF-M: (1) NF-L has only a few phosphate groups which are probably on its a-helical core 7'27. In contrast, the immunogenic, differentially distributed phosphate groups of NF-H and NF-M are located on their COOH-terminal tails7'24'26'27"361 (2) E. coli alkaline phosphatase removes more than 90% of the phosphate groups from NF-H and NF-M but only 10% of the phosphate groups from NF-L, suggesting a stable in vivo phosphorylation state for NF-L 7. As a consequence, it is difficult to reveal phosphorylation-dependent epitopes on NF-L by enzymatic dephosphorylation 7'27'43.
However, there are several other possible explanations for the observed preferences of our antibodies:
(1) Our antibodies distinguish between isoforms that are modified post-translationally other than by phosphorylation. To explain the results, we would have to postulate that our antibodies fail to recognize a certain modification which would have to be labile to denaturation or reduction by the SDS sample buffer. For instance, our epitopes might be destroyed by formation of disulfide bonds between NF-L molecules. Evidence for a dimeric structure is reported for NF-L, as well as for other intermediate filaments under non-reducing conditions~9; and sedimentation studies undertaken to understand the arrangement of the polypeptide chains even suggest a tetrameric structure of NF-L in aqueous solution m.
(2) Our antibodies recognize an epitope which becomes masked and unmasked as the quaternary structure of the filament changes with its functional state. There are examples for masking of epitopes on intermediate filaments. Most of them occur generally, though, independent of the developmental stage of the cell. For instance, antibodies that recognize GFAP core domain epitopes stain this protein in immunoblots but fail to react with their antigen in tissueS2; and there is an early report of an NF-L antiserum that stains only in immunobiots, and not in formaldehyde-fixed tissue sections or cell cultures1.
In a few cases antibodies recognized epitopes that were masked and unmasked with the functional state of the cytoskeleton, e.g. an epitope on glial filaments was masked in certain phases of the cell cycle 16. Antigenic sites on NF-M and NF-H were accessible on blots but not in aldehyde-fixed tissue sections of neonatal retina and 7-day cerebellum, although they were detected in adult sections 22. An intriguing possibility is that the conformational change to which our antibodies are sensitive is induced by the phosphorylation of NF-H. This molecule, as well as NF-M, is known to undergo strong conformational changes upon phosphorylation resulting in a considerably higher apparent molecular weight for the phosphorylated form in electrophoresis 7. It is thought that phosphorylation stabilizes compacted 239 forms of neurofilaments with specific functions 4s. Moreover, the existence of early, immature neurofilament forms containing NF-L and NF-M is postulated ~. Loss of an antigenic site subsequent to the late phosphorylation of NF-H might explain some of the staining patterns of our antibodies.
(3) Our antibodies recognize a binding site Jbr another molecule on NF-L, e.g. in some functional states the epitope is masked by the ligand. For NF-L, binding interactions with a variety of proteins are suggested: a binding site has been postulated for brain spectrin in the N-terminal head region of the molecule 1~, and another one for synapsin 1 with a binding ratio of 1:1 (ref. 44 ). MAP2 and tau-protein were found to bind with a calculated ratio of 1:30 and 1:3, respectively, to the core domain~2; interaction of the latter with our epitopes could explain some of our results, as tau is axon-specific.
Furthermore, binding of NF-L or its degradation products to single-stranded RNA and DNA is reported and postulated to be one step of a hypothesized feedback regulation 5°. As a last possibility, neurofilaments may interact with each other by binding of the carboxy-terminal ends of the high molecular weight NF proteins to the NF-L core of another filament, as is suggested by gelation studies of native neurofilaments 2s.
In summary, our findings suggest an epitope on NF-L whose presence is regulated depending on the functional state of the neurofilament, either by means of post-translational modifications, by a differential build-up of the filament, or by binding of a ligand to the 68 kDa neurofilament protein. Our results show that monoclonal antibodies, by virtue of their high specificity, are sensitive probes for small protein modifications and heterogeneities that cannot easily be detected by analytical methods alone.
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